Antioxidant, antiglycation and inhibitory potential of Saraca ashoka flowers against the enzymes linked to type 2 diabetes and LDL oxidation

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 1, 2012, Pages 57-65

  Prathapan, A ^a   Nampoothiri, Suresh V ^a   Mini, S ^a,b   Raghu, K G ^a  

^a REGIONAL RESEARCH LABORATORY CSIR   (India)

^b UNIVERSITY OF KERALA   (India)

Author keywords

glucosidase; Antiglycation; C2C12 cells; LDL oxidation; Reactive oxygen species

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA GLUCOSIDASE; AMYLASE; ANTIDIABETIC AGENT; ANTIOXIDANT; GLUTATHIONE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; SARACA ASHOKA EXTRACT; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ANTIGLYCATION PROPERTY; ANTIOXIDANT ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FLOWER; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LIPID OXIDATION; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; REVIEW;

ALPHA-AMYLASES; ALPHA-GLUCOSIDASES; ANTIOXIDANTS; CELL SURVIVAL; CELLS, CULTURED; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FABACEAE; FLAVONOIDS; FLOWERS; GLUTATHIONE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 84859834130     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. CERIELLO A. Oxidative stress and glycemic regulation. Metabolism 2000;49(2 Suppl 1):27-29. (Pubitemid 30091790)
2. BAYNES JW, THORPE SR. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 1999;48:1-9. (Pubitemid 29019345)
3. YOUNG IS, TATE S, LIGHTBODY JH, MCMASTER D, TRIMBLE ER. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 1995;18:833-840.
4. SAXENA AK, SRIVASTAVA P, KALE RK, BAQUER NZ. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 1993;45:539-542. (Pubitemid 23064556)
5. MCLENNAN S V, HEFFERNAN S, WRIGHT L, RAE C, FISHER E, YUE DK, TURTLE JR. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991;40:344-348.
6. TSAI EC, HIRSCH IB, BRUNZELL JD, CHAIT A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994;43:1010-1014. (Pubitemid 24230705)
7. KAWAMURA M, HEINECKE JW, CHAIT A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide dependent pathway. J Clin Invest 1994;94:771-778. (Pubitemid 24251010)
8. HAFFNER SM. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocr Rev 1998;19:583-592. (Pubitemid 28467712)
9. GRAY DM. Carbohydrate digestion and absorptionrole of small intestine. N Engl J Med 1995;29:1225-1230.
10. KRENTZ AJ, BAILEY CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005;65:385-411. (Pubitemid 40227460)
11. HALLIWELL B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001;18:685-716. (Pubitemid 32948277)
12. CERIELLO A, GIUGLIANO D, QUATRARO A, DONZELLA C, DIPALO G, LEFEBVRE PJ. Vitamin e reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care 1991;14:68-72.
13. DURAISAMY Y, GAFFNEY J, SLEVIN M, SMITH CA, WILLIAMSON K, AHMED N. Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: comparison with aminoguanidine. Mol Cell Biochem 2003;246:143-153. (Pubitemid 36798735)
14. XI M, HAI C, TANG H, CHEN M, FANG K, LIANG X. Antioxidant and antiglycation properties of total saponins extracted from traditional chinese medicine used to treat diabetes mellitus. Phytother Res 2008;22:228-237. (Pubitemid 351363243)
15. APOSTOLIDIS E, KWON Y-I, SHETTY K. Potential of cranberry-based herbal synergies for diabetes and hypertension management. Asia Pac J Clin Nutr 2006;15:433-441. (Pubitemid 44423426)
16. GHOSH S, MAJUMDER M., MAJUMDER S, GANGULY NK, CHATTERJEE B P. Saracin-A lectin from Saraca indica seed integument induces apoptosis in human T-lymphocytes. Arch Biochem Biophys 1999;371:163-168.
17. VARGHESE CD, SATISH CN, PANIKKAR KR. Potential anticancer activity of Saraca ashoka extracts towards transplantable tumours in mice. Ind J Pharm Sci 1992;54:37-40.
18. CIBIN TR, GAYATHRI DEVI D, ABRAHAM A. Chemo prevention of skin cancer by the flavonoid fraction of Saraca ashoka. Phytother Res 2009;24:666-672.
19. CHHETRI DR, PARAJULI P, SUBBA GC. Antidiabetic plants used by Sikkim and Darjeeling Himalayan tribes, Ind J Ethnopharmacol 2005;99:199-202. (Pubitemid 40731480)
20. ZHISHEN J, MENGCHENG T, JIANMING W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem 1999;64:555-559. (Pubitemid 29060787)
21. PRIETO P, PINEDA M, AGUILAR M. Spectrophotometric quantitation of antioxidant capacity through formation of a phosphomolybdenum complex: specific application to the determination of vitamin E. Annal Biochem 1999;269, 337-341. (Pubitemid 29201033)
22. MOSMANN T. Rapid colorimetric assay for cellular growth and survival: Applications to proliferation and cytotoxicity assays. J Immunol Meth 1983;65:55-63. (Pubitemid 14203433)
23. ALIA M, MATEOS, RAMOS S, LECUMBERRI E, BRAVO L, GOYA L. Influence of quercetin and rutin on growth and the antioxidant defense system in a human hepatoma cell line (HepG2). Eur J Nutr 2006;45:19-28. (Pubitemid 43221280)
24. BODEA G O D, MUNTEANU, MC, DINU D, SERBAN AI, ROMING FI, COSTACHE M, DINISCHIOTU A. Influence of deoxynivalenol on the oxidative status of HepG2 cells. Romanian Biotech Lett 2009;14:4349-4359.
25. APOSTOLIDIS E, KWON Y-I, SHETTY K. Inhibitory potential of herb, fruit and fungal-enriched cheese against key enzymes linked to type-2 diabetes and hypertension. Inn Food Sci Emerg Technol 2007;8:46-54. (Pubitemid 46217979)
26. JEDSADAYANMATA A. In vitro antiglycation activity of arbutin. Naresuan Univ J 2005;3:35-41.
27. KOTAMBALLI N, CHIDAMBARA M, RAVENDRA PS, JAYAPRAKASHA KG. Antioxidant activities of grape (Vitis vinifera) Pomace Extracts. J Agric Food Chem 2002;50:5909-5914. (Pubitemid 35155313)
28. MATEOS R, BRAVO L. Chromatographic and electrophoretic methods for the analysis of biomarkers of oxidative damage to macromolecules (DNA, lipids, and proteins). J Sep. Sci 2007;30:175-191. (Pubitemid 46322545)
29. JAIN A, MARTENSSON J, STOLE E, AULD P A M, MEISTER A. Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci 1991;88:1913-1917. (Pubitemid 21916337)
30. CHIASSON JL, RABASA-LHORET R. Prevention of type 2 diabetes: insulin resistance and beta-cell function. Diabetes 2004;53:S34-38. (Pubitemid 39564520)
31. ULRICH P, CERAMI A. Protein glycation, diabetes, and aging. Rec Progr Horm Res 2001;56:1-21.
32. BAYNES JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-412.
33. JAMES W, ANDERSON MD, MAYA S, GOWRI, JAN T R D, LAURA N R N. Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with type 2 diabetes mellitus. J Am Coll Nutr 1999;18:451-461. (Pubitemid 29455718)
34. WIZTUM JL, STEINBERG D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-1792.
35. KINSELLA JE, FRANKEL E, GERMAN B, KANNER J. Possible mechanism for the protective role of antioxidants in wine and plant foods. Food Technol 1993:47, 85-89.
36. NAKAGAWA T, YOKOZAWA T, TERASAWA K, SHU S, JUNEJA LR. Protective activity of green tea against free radical and glucose mediated protein damage. J Agric Food Chem 2002;50:2418-2422. (Pubitemid 34275319)